For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $13.43 up 0.22% from its previous closing price of $13.4. In other words, the price has increased by $0.22 from its previous closing price. On the day, 0.9 million shares were traded. ORIC stock price reached its highest trading level at $13.8 during the session, while it also had its lowest trading level at $13.115.
Ratios:
For a deeper understanding of ORIC Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.13 and its Current Ratio is at 16.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $15.
On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.Wells Fargo initiated its Overweight rating on October 31, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 06 ’25 when Piscitelli Dominic sold 11,000 shares for $14.52 per share. The transaction valued at 159,719 led to the insider holds 48,317 shares of the business.
Chacko Jacob sold 37,461 shares of ORIC for $461,520 on Oct 06 ’25. The PRESIDENT AND CEO now owns 531,419 shares after completing the transaction at $12.32 per share. On Oct 06 ’25, another insider, Dominic Piscitelli, who serves as the Officer of the company, bought 50,000 shares for $14.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 1304361728 and an Enterprise Value of 1029933696.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.66, which has changed by 0.42250526 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is 16.39%, while the 200-Day Moving Average is calculated to be 47.18%.
Shares Statistics:
For the past three months, ORIC has traded an average of 1.37M shares per day and 1303360 over the past ten days. A total of 86.19M shares are outstanding, with a floating share count of 55.10M. Insiders hold about 43.27% of the company’s shares, while institutions hold 62.05% stake in the company. Shares short for ORIC as of 1760486400 were 13020257 with a Short Ratio of 9.48, compared to 1757894400 on 9528668. Therefore, it implies a Short% of Shares Outstanding of 13020257 and a Short% of Float of 13.58.
Earnings Estimates
A comprehensive evaluation of ORIC Pharmaceuticals Inc (ORIC) is underway, with the input of 11.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.29 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.29 and -$2.53 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.71, with 11.0 analysts recommending between -$1.03 and -$2.84.
